Publication Name	World Journal of Clinical Oncology
Manuscript ID	65123
Country	Türkiye

Received	2021-02-28 11:06
Peer-Review Started	2021-02-28 11:13
To Make the First Decision
Return for Revision	2021-04-27 03:59
Revised	2021-05-05 18:58
Second Decision	2021-12-16 03:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-12-23 05:57
Articles in Press	2021-12-23 05:57
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-12-13 01:55
Typeset the Manuscript	2022-01-17 13:18
Publish the Manuscript Online	2022-01-22 06:17

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Role of radiotherapy in oligometastatic breast cancer: Review of the literature
Manuscript Source	Invited Manuscript
All Author List	Caglayan Selenge Beduk Esen, Melis Gultekin and Ferah Yildiz
ORCID	Author(s) ORCID Number Caglayan Selenge Beduk Esen http://orcid.org/0000-0001-9967-8177 Melis Gultekin http://orcid.org/0000-0002-1806-2619 Ferah Yildiz http://orcid.org/0000-0002-2557-8103
Funding Agency and Grant Number
Corresponding Author	Caglayan Selenge Beduk Esen, MD, Research Scientist, Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Altındağ, Ankara 06100, Türkiye. selengebedk@gmail.com
Key Words	Breast cancer; Oligometastatic; Radiotherapy; Locoregional treatment; Ablative therapy; Metastasis-directed therapy
Core Tip	Radiotherapy (RT) has been traditionally used for only palliation of the symptoms caused by metastatic lesions. However, in recent years the concept of oligometastatic disease has been introduced in Cancer Medicine as a clinical scenario with a limited number of metastases (≤ 5) and involved organs (≤ 2) with controlled primary tumor. The main hypothesis in oligometastatic disease is that locoregional treatment of primary tumor site and metastasis-directed therapies with surgery and/or RT may improve outcomes. The current review will provide up-to-date information about the role of RT in oligometastatic breast cancer.
Publish Date	2022-01-22 06:17
Citation	Beduk Esen CS, Gultekin M, Yildiz F. Role of radiotherapy in oligometastatic breast cancer: Review of the literature. World J Clin Oncol 2022; 13(1): 39-48
URL	https://www.wjgnet.com/2218-4333/full/v13/i1/39.htm
DOI	https://dx.doi.org/10.5306/wjco.v13.i1.39

Full Article (PDF)	WJCO-13-39.pdf
Full Article (Word)	WJCO-13-39.docx
Manuscript File	65123_Auto_Edited-ZMG-Filipodia.docx
Answering Reviewers	65123-Answering reviewers.pdf
Audio Core Tip	65123-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	65123-Conflict-of-interest statement.pdf
Copyright License Agreement	65123-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	65123-Language certificate.pdf
Peer-review Report	65123-Peer-review(s).pdf
Scientific Misconduct Check	65123-CrossCheck.png
Scientific Misconduct Check	65123-Bing-Gong ZM-2.png
Scientific Editor Work List	65123-Scientific editor work list.pdf
CrossCheck Report	65123-CrossCheck report.pdf